Is Calidi Biotherapeutics, Inc. (CLDI) a Buy, Sell, or Hold?
AMEX : CLDI
Calidi Biotherapeutics, Inc.
$0.1206 USD
$0.01 (4.33%)
- Volume
- 1.38M
- Average Volume
- 6.14M
- Market Capitalization
- $888.46K
- P/E Ratio
- -0.02
- Dividend Yield
- 0.00%
- Price Target
- $5.50
- Year High
- $10.92
- Year Low
- $0.11
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.92
Insider Activity Summary (Last 12 Months)
Insiders Buying
24
Insiders Selling
1
Amount of Insider Selling
$10000
CLDI Insider Buying/Selling by Quarter
CLDI Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Sanders Corazon (Corsee) D. | director: | 2026-06-17 | 0 | 2026-06-29 | |
| Camaisa Allan | director | 2025-12-12 | S-Sale | 1.455 | 2025-12-16 |
| Poma Eric E | officer: Chief Executive Officer | 2025-09-03 | A-Award | 1.58 | 2025-09-05 |
| Fernandez Santidrian Antonio | officer: Chief Scientific Officer | 2025-09-03 | A-Award | 1.58 | 2025-09-05 |
| Jackson Andrew C. | officer: Chief Financial Officer | 2025-09-03 | A-Award | 1.58 | 2025-09-05 |
| Lincoln Alternative Strategies LLC | 10 percent owner | 2025-08-20 | 0 | 2025-08-27 | |
| Schoeneck James A | director | 2025-08-21 | P-Purchase | 2 | 2025-08-25 |
| Schoeneck James A | director | 2025-08-21 | P-Purchase | 2 | 2025-08-25 |
| Poma Eric E | director, officer: Chief Executive Officer | 2025-08-21 | P-Purchase | 2 | 2025-08-25 |
| Poma Eric E | director, officer: Chief Executive Officer | 2025-08-21 | P-Purchase | 2 | 2025-08-25 |
| Leftwich Scott | director | 2025-08-21 | P-Purchase | 2 | 2025-08-25 |
| Leftwich Scott | director | 2025-08-21 | P-Purchase | 2 | 2025-08-25 |
| Jackson Andrew C. | officer: Chief Financial Officer | 2025-08-21 | P-Purchase | 2 | 2025-08-25 |
| Jackson Andrew C. | officer: Chief Financial Officer | 2025-08-21 | P-Purchase | 2 | 2025-08-25 |
| Schoeneck James A | director | 2025-07-09 | A-Award | 0.7 | 2025-07-15 |
| Stewart Alan R. | director | 2025-07-09 | A-Award | 0.7 | 2025-07-15 |
| Peoples George | director | 2025-07-09 | A-Award | 0.7 | 2025-07-15 |
| Leftwich Scott | director | 2025-07-09 | A-Award | 0.7 | 2025-07-15 |
| Poma Eric E | director, officer: Chief Executive Officer | 2025-04-22 | A-Award | 0.469 | 2025-04-25 |
| Poma Eric E | director, officer: Chief Executive Officer | 2025-04-22 | 0 | 2025-04-25 | |
| Stewart Alan R. | director | 2024-12-31 | A-Award | 0 | 2025-01-03 |
| Leftwich Scott | director | 2024-12-31 | A-Award | 0 | 2025-01-03 |
| Camaisa Allan | director, officer: CEO and Chairman of the Board | 2024-12-17 | S-Sale | 1.62 | 2024-12-18 |
| Leftwich Scott | director | 2024-09-20 | A-Award | 1.09 | 2024-10-15 |
| Peoples George | director | 2024-09-20 | A-Award | 1.09 | 2024-10-15 |
| Schoeneck James A | director | 2024-09-20 | A-Award | 1.09 | 2024-10-15 |
| Stewart Alan R. | director | 2024-09-20 | A-Award | 1.09 | 2024-10-15 |
| Camaisa Allan | director, 10 percent owner, officer: CEO and Chairman of the Board | 2024-09-26 | A-Award | 1.15 | 2024-09-30 |
| Peoples George | director | 2024-07-01 | A-Award | 0.193 | 2024-07-11 |
| Peoples George | director: | 2024-07-01 | 0 | 2024-07-11 | |
| Leftwich Scott | director | 2024-06-28 | A-Award | 0 | 2024-07-02 |
| Schoeneck James A | director | 2024-06-28 | A-Award | 0 | 2024-07-02 |
| Stewart Alan R. | director | 2024-06-28 | A-Award | 0 | 2024-07-02 |
| Leftwich Scott | director | 2024-03-29 | A-Award | 0 | 2024-07-02 |
| Schoeneck James A | director | 2024-03-29 | A-Award | 0 | 2024-07-02 |
| Stewart Alan R. | director | 2024-03-29 | A-Award | 0 | 2024-07-02 |
| Camaisa Allan | director, 10 percent owner, officer: CEO and Chairman of the Board | 2024-06-17 | A-Award | 0.215 | 2024-06-20 |
| Minev Boris Radoslavov | officer: Interim Chief Medical Officer | 2024-06-17 | A-Award | 0.195 | 2024-06-20 |
| Campbell Wendy Pizarro | officer: Chief Admin. and Legal Officer | 2024-06-17 | A-Award | 0.195 | 2024-06-20 |
| Campbell Wendy Pizarro | officer: Chief Admin. and Legal Officer | 2024-06-17 | A-Award | 0.195 | 2024-06-20 |
| Jackson Andrew C. | officer: Chief Financial Officer | 2024-06-17 | A-Award | 0.195 | 2024-06-20 |
| Schoeneck James A | director | 2024-06-03 | M-Exempt | 0.2 | 2024-06-05 |
| Schoeneck James A | director | 2024-06-03 | M-Exempt | 0.2 | 2024-06-05 |
| Schoeneck James A | director | 2024-06-03 | A-Award | 0.3 | 2024-06-05 |
| Schoeneck James A | director | 2024-06-03 | M-Exempt | 0.2 | 2024-06-05 |
| Schoeneck James A | director | 2024-06-03 | M-Exempt | 0.2 | 2024-06-05 |
| Schoeneck James A | director | 2024-06-03 | M-Exempt | 0.2 | 2024-06-05 |
| Schoeneck James A | director | 2024-06-03 | M-Exempt | 0.2 | 2024-06-05 |
| Schoeneck James A | director | 2024-04-18 | A-Award | 0.4 | 2024-04-22 |
| Schoeneck James A | director | 2024-04-18 | A-Award | 0.6 | 2024-04-22 |
| LaPre David | director: | 2024-01-01 | 0 | 2024-03-12 |